The naturally occurring cannabinoids in the cannabis plant are compounds that interact with your body to potentially produce a range of different benefits and effects. In this article, you will find all relevant information aimed at providing you with an understanding of the importance of cannabinoids in the field of medicinal cannabis and their potential contribution to enhancing your health and well-being.
Cannabinoids are a group of chemical compounds found in the cannabis plant. They interact with the endocannabinoid system in the bodies of humans and other animals, which plays a role in regulating various physiological processes, including mood, memory, pain perception, appetite, and immune response.
There are three main types of cannabinoids:
Phytocannabinoids: These are cannabinoids naturally produced by the cannabis plant. The most well-known and widely studied phytocannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD).
THC is the primary psychoactive compound in cannabis, responsible for the "high" or euphoric effect. It also has potential therapeutic effects, such as pain reductionand appetite stimulation.
CBD is another major cannabinoid found in cannabis. Unlike THC, CBD is non-psychoactive and does not cause a "high." It has attracted attention for its potential therapeutic benefits, including anti-inflammatory, analgesic, and anti-anxiety properties.
Endocannabinoids: These are cannabinoids that our body naturally produces. Anandamide and 2-Arachidonoylglycerol (2-AG) are the two main endocannabinoids identified. They play a role in maintaining homeostasis by binding to cannabinoid receptors in the endocannabinoid system.
Synthetic Cannabinoids: These are cannabinoids chemically synthesized in a laboratory. They are often designed to mimic the effects of natural cannabinoids and are sometimes used for research purposes or even illegally as recreational drugs. Synthetic cannabinoids can have unpredictable and potentially dangerous effects on human health.
The two main sources of cannabinoids are:
Cannabis Plants: This is the most well-known source of cannabinoids, which are produced in specialized glands known as trichomes. The two most common and widely studied cannabinoids in cannabis plants are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). However, there are over 100 other cannabinoids, each with different effects and potential therapeutic properties.
Hemp Plant: Hemp is a variety of the cannabis plant grown for industrial uses, such as fibers, seeds, and oil. It has a low THC content (typically less than 0.3%), meaning it does not produce the psychoactive effects associated with cannabis. Hemp is also a significant source of CBD, used in various health and wellness products.
It is worth noting that cannabinoids can also be synthesized in laboratories; however, the primary natural sources of cannabinoids are cannabis plants and hemp plants. The content and types of cannabinoids in these plants can vary significantly depending on the strain, growing conditions, and cultivation methods.
Cannabinoids can be broadly divided into two groups: natural cannabinoids and synthetic cannabinoids.
Natural Cannabinoids are compounds that naturally occur in the cannabis plant. The most well-known and extensively studied natural cannabinoids include THC, CBD, cannabinol (CBN), and cannabigerol (CBG).
Synthetic Cannabinoids are compounds artificially created in a lab to mimic the effects of natural cannabinoids. They are often designed to interact with the same receptors in the ECS as natural cannabinoids. Synthetic cannabinoids are sometimes referred to as "designer drugs" or "research chemicals." While they are typically developed for medical research purposes, they are also misused as recreational drugs.
A key difference between synthetic and natural cannabinoids is that synthetic cannabinoids can vary significantly in potency, effects, and safety profile. These differences make synthetic cannabinoids potentially more dangerous than natural cannabinoids. Synthetic cannabinoids are also associated with a range of side effects, including severe anxiety, hallucinations, paranoia, heart palpitations, and even life-threatening conditions.
In summary, natural cannabinoids like THC and CBD are well-researched, have known effects, and are non-toxic, whereas synthetic cannabinoids can be highly variable and carry a higher risk of side effects. The use of natural cannabinoids for medical purposes is better researched and regulated than the use of synthetic cannabinoids, which are often considered a riskier option due to their potential for unpredictable and harmful effects.
How Do Cannabinoids in Medical Cannabis Work?
The interaction between cannabinoids and the ECS, along with their potential applications, is a significant area of research interest. Medical cannabis, where cannabis or cannabinoids are used for therapeutic purposes, has gained attention for managing various conditions such as chronic pain, epilepsy, multiple sclerosis, and more.
THC (Delta-9-Tetrahydrocannabinol)
THC is the primary psychoactive compound in cannabis. It binds to cannabinoid receptors in the brain and central nervous system. This interaction leads to the release of dopamine and other neurotransmitters, resulting in the "high" associated with cannabis use. Additionally, THC also has analgesic (pain-relieving) properties.
CBD is another major cannabinoid found in cannabis but does not produce the same psychoactive effects as THC. It is thought to have anti-inflammatory, analgesic (pain-relieving), anxiolytic (anti-anxiety), and antipsychotic properties. The effects of CBD are complex and not fully understood, but it appears to modulate the effects of THC and influence various signaling pathways in the body.
There are over 100 different cannabinoids in cannabis, each with its own potential effects. For example, cannabinol (CBN) is attributed with sedative effects, while cannabigerol (CBG) may have anti-inflammatory properties.
The endocannabinoid system (ECS) is a complex cell-signaling system in the body that plays a crucial role in regulating a variety of important physiological processes.
The ECS consists of three main components:
The ECS is involved in regulating a wide range of physiological processes, including but not limited to:
Ongoing research into the ECS has led to the development of medications and therapies targeting the ECS for various conditions. Furthermore, the interaction between the ECS and cannabinoids found in cannabis plants (such as THC and CBD) is of particular interest due to their potential therapeutic effects, although more research is needed to fully understand these interactions.
The Effects of Cannabinoids on Body and Mind
The effects of cannabinoids on the body and mind can vary depending on the strain, concentration, and individual differences in metabolism and sensitivity. Here is an overview of the effects of cannabinoids:
Tetrahydrocannabinol (THC)
THC is the primary psychoactive compound in cannabis, responsible for the "high" or euphoric feeling often associated with marijuana use. Its effects on the body and mind include:
Cannabidiol (CBD)
CBD is a non-psychoactive cannabinoid known for its potential therapeutic effects. Unlike THC, it does not produce a "high" and can even counter some of THC's psychoactive effects. The effects of CBD include:
Pain Management
Cannabinoids, particularly THC and CBD, have shown potential in treating various types of pain, including chronic pain, neuropathic pain, and pain associated with conditions such as multiple sclerosis. Studies suggest that cannabinoids may modulate pain perception through their interaction with cannabinoid receptors in the nervous system.
Neurological Disorders
Cannabinoids have been studied for their potential in treating neurological disorders such as epilepsy, multiple sclerosis, and Parkinson’s disease. In particular, CBD has gained attention due to its anticonvulsant properties and potential neuroprotective effects.
Cancer-Related Symptoms
Cannabinoids have been investigated for their potential to relieve cancer-related symptoms, including chemotherapy-induced nausea and vomiting, as well as pain and loss of appetite. Synthetic cannabinoids like dronabinol and nabilone are approved in some countries for the treatment of these symptoms.
Individual responses to cannabinoids can vary widely, and more research is needed to fully understand their effects. Here are some potential risks and side effects associated with cannabinoids:
Chronic use of high-THC cannabis can lead to cognitive impairment, particularly affecting memory, attention, and learning abilities. This is especially critical for individuals under 25, whose brains are still developing.
Some people use cannabis to alleviate symptoms of anxiety and depression. However, heavy or prolonged use, particularly of high-THC strains, can increase the risk of developing or worsening mental health disorders, especially in individuals with a predisposition to these conditions.
Cannabinoids can interact with certain medications, potentially reducing their effectiveness or causing unwanted side effects. It is essential to consult a healthcare professional before using cannabinoids, especially if you are taking other medications.
Making informed decisions about cannabinoid use is important. If you are considering cannabinoids for medical purposes, it is advisable to consult a healthcare professional who can provide guidance based on your individual health condition and needs.
The use of cannabinoids, especially THC and CBD, has gained popularity due to their potential therapeutic effects. Here is an overview of common methods:
This is one of the most common methods of using cannabinoids, particularly THC. Cannabinoids are quickly absorbed into the bloodstream through the lungs. However, smoking can negatively affect lung health and is not recommended for long-term use.
Edible products infused with cannabinoids, such as brownies, gummies, chocolates, and more, are another option. Cannabinoids are absorbed through the digestive system, so the effects may take longer to set in (often 30 minutes to 2 hours) and tend to last longer.
This includes tinctures, oils, and sprays applied under the tongue. This method allows cannabinoids to be absorbed more quickly into the bloodstream through the blood vessels under the tongue. Effects typically begin within 10–20 minutes.
In addition to smoking, vaporizing is another inhalation method. Vaporizers heat cannabinoids to a temperature that releases them as vapor without burning, reducing potential lung damage associated with smoking.
Nasal sprays are designed to deliver cannabinoids through the nasal mucosa, enabling rapid absorption into the bloodstream.
Cannabinoid-enriched transdermal patches can be adhered to the skin, allowing cannabinoids to be released gradually into the bloodstream over time.
Cannabinoid-infused creams, lotions, balms, and oils can be applied directly to the skin. They are commonly used for localized relief from pain or inflammation.
When dosing cannabinoids, several key factors should be considered. Cannabinoids are active compounds in cannabis that interact with the body’s ECS, which plays a role in regulating various physiological processes.
Dosage can vary significantly depending on factors like the specific cannabinoid, individual tolerance, desired effect, and method of consumption. Here are some important considerations:
1. Type of Cannabinoid - The two most well-known cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). THC is responsible for the psychoactive effects of cannabis, while CBD is non-psychoactive and has potential therapeutic benefits. Different cannabinoids can have different effects and may require different dosages.
2. Tolerance - Individual tolerance to cannabinoids can vary greatly. Beginners and those with low tolerance should start with lower doses to avoid unwanted effects.
3. Body Weight and Metabolism - Body weight and metabolism can affect how cannabinoids are processed in the body. Generally, individuals with higher body weight may require slightly higher doses.
4. Start Low and Go Slow - This is a common guideline for beginners. Start with a low dose and gradually increase it until the desired effect is achieved. This approach helps avoid excessive consumption and unwanted side effects.
5. Monitor Effects - Pay attention to how your body responds to different doses. Track the effects and adjust the dosage as needed.
6. Potential Interactions - Cannabinoids can interact with certain medications. If you are taking other medications, consult a healthcare provider before using cannabinoids.
7. Individual Sensitivity - Some individuals may be more sensitive to cannabinoids and experience effects at lower doses than others.
The duration of cannabinoid effects can vary depending on the method of consumption. Smoking or vaping may produce quicker effects that wear off sooner than edibles, which take longer to activate but last longer.
Certain health conditions can affect how your body responds to cannabinoids. For example, individuals with anxiety disorders should be cautious with THC, as it can sometimes exacerbate anxiety symptoms.
It's important to understand that there is no one-size-fits-all approach to cannabinoid dosing. What works well for one person may not necessarily be ideal for another. If you are new to using cannabinoids, consult your doctor to ensure a reasonable and safe dosage of medical cannabis.
If you suffer from a chronic condition, you may qualify for a medical cannabis therapy. The use of cannabis therapy is not restricted to specific conditions or severity levels but can be considered when standard treatments have not achieved the desired results.
If you'd like to learn more about "how to become a cannabis patient," read our article.
1. Huestis, M.A. (2007). Pharmacokinetics of cannabinoids in humans. Chemistry & Biodiversity, 4(8), 1770-1804.
2. Campos, AC, Fogaça, MV, Sonego, AB, & Guimarães, FS (2016). Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacological Research, 112, 119-127.
3. Russo, E. B. (2008). Cannabinoids in the treatment of difficult-to-treat pain. Therapeutics and Clinical Risk Management, 4(1), 245-259.
4. Lynch, M.E., & Campbell, F. (2011). Cannabinoids for the treatment of chronic non-cancer pain; a systematic review of randomized trials. British Journal of Clinical Pharmacology, 72(5), 735-744.
5. Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., ... & Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine, 376(21), 2011-2020.
6. Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., & Pinto, J. P. (2010). Neuroimaging in social anxiety disorder: A systematic review of the literature. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(4), 565-580.
7. Ahmedzai, S., Carlyle, D. L., Calder, I. T., & Moran, F. (2013). Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in the chemotherapy of lung cancer. British Journal of Cancer, 48(5), 657-663.
8. Whiting, PF, Wolff, RF, Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, AV, ... & Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456-2473.
